Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma by Rossi, Alessandro et al.
Contents lists available at ScienceDirect
Psychiatry Research
journal homepage: www.elsevier.com/locate/psychres
Personal resources and depression in schizophrenia: The role of self-esteem,
resilience and internalized stigma
Alessandro Rossia,⁎, Silvana Galderisib, Paola Roccac, Alessandro Bertolinod, Paola Ruccie,
Dino Gibertonie, Paolo Strattaa, Paola Buccib, Armida Muccib, Eugenio Agugliaf,
Giovanni Amodeog, Mario Amoreh, Antonello Bellomoi, Roberto Brugnolij, Grazia Caforiod,
Bernardo Carpiniellok, Liliana Dell’Ossol, Fabio di Fabiom, Massimo di Giannantonion,
Carlo Marchesio, Palmiero Monteleonep, Cristiana Montemagnic, Lucio Oldaniq, Rita Ronconer,
Emilio Sacchettis,w, Paolo Santonastasot, Alberto Siracusanou, Patrizia Zeppegnov, Mario Majb,
Italian Network for Research on Psychoses1
a Department of Biotechnological and Applied Clinical Sciences, Section of Psychiatry, University of L’Aquila, L’Aquila, Italy
b Department of Psychiatry, University of Naples SUN, Naples, Italy
c Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy
d Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
e Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
f Department of Clinical and Molecular Biomedicine, Psychiatry Unit, University of Catania, Catania, Italy
g Department of Molecular Medicine and Clinical Department of Mental Health, University of Siena, Siena, Italy
h Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, Section of Psychiatry, University of Genoa, Genoa, Italy
i Department of Medical Sciences, Psychiatry Unit, University of Foggia, Foggia, Italy
j Department of Neurosciences, Mental Health and Sensory Organs, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy
k Department of Public Health, Clinical and Molecular Medicine, Section of Psychiatry, University of Cagliari, Cagliari, Italy
l Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy
m Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy
n Department of Neuroscience and Imaging, Chair of Psychiatry, G. d′Annunzio University, Chieti, Italy
° Department of Neuroscience, Psychiatry Unit, University of Parma, Parma, Italy
p Department of Medicine and Surgery, Chair of Psychiatry, University of Salerno, Salerno, Italy
q Department of Psychiatry, University of Milan, Milan, Italy
r Department of Life, Health and Environmental Sciences, Unit of Psychiatry, University of L’Aquila, L’Aquila, Italy
s Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy
t Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy
u Department of Systems Medicine, Chair of Psychiatry, Tor Vergata University of Rome, Rome, Italy
v Department of Translational Medicine, Psychiatric Unit, University of Eastern Piedmont, Novara, Italy
w Department of Mental Health, Spedali Civili Hospital, Brescia, Italy
A B S T R A C T
Depression in schizophrenia represents a challenge from a diagnostic, psychopathological and therapeutic
perspective. The objective of this study is to test the hypothesis that resilience and self-stigma affect depression
severity and to evaluate the strength of their relations in 921 patients with schizophrenia. A structural equation
model was tested where depression is hypothesized as affected by resilience, internalized stigma, gender and
negative symptoms, with the latter two variables used as exogenous covariates and the former two as mediators.
The analysis reveals that low resilience, high negative symptoms, female gender were directly associated with
depression severity, and internalized stigma acted only as a mediator between avolition and resilience, with
similar magnitude. The cross-sectional study design and the variable selection limit the generalizability of the
study results. The model supports a complex interaction between personal resources and negative symptoms in
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predicting depression in schizophrenia. The clinical implication of these findings is that personal resources could
be a significant target of psychosocial treatments.
1. Introduction
Depression is a frequently occurring symptom in schizophrenia,
although often under-recognized and under-treated (Mulholland and
Cooper, 2000). The estimated prevalence ranges from 7% to 80%
(Rabany et al., 2013), with a modal rate of 25%, suggesting a strong
variation that goes beyond sample heterogeneity.
Depressive symptoms are associated with greater impairments in
well-being and global functioning, as well as enhanced risk of suicide
(Schennach-Wolff et al., 2011), making depression in schizophrenia a
key area of assessment and intervention. Although this issue has been
explored from historical, pathophysiological, diagnostic and ther-
apeutic perspectives (Chiappelli et al., 2014a; Chemerinski et al., 2008;
Häfner, 2005; Siris, 2000), several inconsistencies in depression as-
sessment in schizophrenia emerged, especially due to a possible overlap
with other psychopathological dimensions, including negative symp-
toms. Indeed, several studies have analyzed the association between
depression and other symptoms in schizophrenic patients, with mixed
results (Lako et al., 2012; Rabany et al., 2011; Rocca et al., 2005). The
issue of the overlap between negative and depressive symptoms has
been debated in the literature, with the prevailing view of a moderate
association, while a low association with positive symptoms has been
reported (Majadas et al., 2012).
The overlap between negative and depressive symptoms may be in
part due to the psychometric properties of the rating scales used rather
than to the characteristics of the illness itself (Rocca et al., 2005), al-
though an overlap between the two constructs cannot be ruled out
(Chiappelli et al., 2014b; Winograd-Gurvich et al., 2006). The use of
new instruments with good psychometric properties to assess negative
symptoms (Carpenter et al., 2016; Daniel et al., 2013; Kirkpatrick et al.,
2011) may help to clarify the issue.
A different perspective has been advocated by Liddle and Barnes
(1988), Liddle et al. (1993), who suggested that depression could be
due to the experience of psychological deficits in schizophrenia. Sub-
jective experience of deficits could represent an indication of vulner-
ability to depression due to psychological or neural mechanisms.
Within this perspective two main aspects as internalized stigma and
resilience could have a role in shaping depression.
Internalized stigma, also referred to as self-stigma, is characterized
by a subjective perception of devaluation, marginalization, secrecy,
shame, and withdrawal (Boyd et al., 2014). People with a severe mental
illness, such as schizophrenia, anticipate social rejection and consider
themselves as devalued members of society (Corrigan et al., 2005).
They may internalize negative stereotypes about mental illness and
respond by self-stigma (Mittal et al., 2012). In accordance with the
current literature, both stigma and lack of empowerment may lead to
depression (Lysaker et al., 2013; Sibitz et al., 2011).
Resilience is a construct encompassing several aspects of personal
resources. It is usually defined as a dynamic process of adaptation to
challenging life conditions that could be protective against mental
disorders (Kim-Cohen, 2007; Rutter, 2006). In patients with schizo-
phrenia, a correlation between resilience and psychosocial functioning
has been reported (Kim et al., 2013; Torgalsboen, 2012) so that this
issue deserves further investigations.
The aim of the present study is to test the hypothesis that resilience
and self-stigma affect depression severity in opposite directions: self-
stigma worsening and resilience improving. This hypothesis has been
verified using a structural equation model (SEM), which allows to
evaluate complex paths linking covariates to an outcome. Using this
approach, we designed a model in which resilience and stigma act as
mediators and gender and negative symptoms are exogenous covari-
ates.
2. Materials and method
2.1. Participants
Data for this study were collected from the Italian Network for
Research on Psychoses study (NIRP). A detailed description of the study
can be found elsewhere (Galderisi et al., 2014). In the NIRP study,
participants were recruited among patients living in the community and
consecutively seen at the outpatient units of 26 Italian university psy-
chiatric clinics and/or mental health departments. Inclusion criteria
were a diagnosis of schizophrenia according to DSM-IV, confirmed with
the Structured Clinical Interview for DSM-IV - Patient version (SCID-I-
P), and an age between 18 and 66 years. Exclusion criteria were: a
history of head trauma with loss of consciousness; a history of moderate
to severe mental retardation or neurological diseases; a history of al-
cohol and/or substance abuse in the last six months; current pregnancy
or lactation; inability to provide an informed consent; treatment mod-
ifications and/or hospitalization due to symptom exacerbation in the
last three months. All patients signed a written informed consent to
participate after receiving a comprehensive explanation of the study
procedures and goals. Approval of the study protocol was obtained from
the Local Ethics Committees of each participating center.
2.2. Procedures
Recruitment took place from March 2012 to September 2013. A
clinical form was filled in with data on age of disease onset, course of
the disease and treatments, using all available sources of information
(patient, family, medical records and mental health workers).
2.3. Study variables
2.3.1. Dependent variable
Depressive symptoms were evaluated using the Calgary Depression
Scale for Schizophrenia (CDSS), a rating scale designed to assess the
level of depression in people with schizophrenia (Addington et al.,
1992, 1994). Higher scores represent higher levels of depression. The
CDSS includes nine items (depression, hopelessness, self-depreciation,
guilty ideas of reference, pathological guilt, morning depression, early
wakening, suicide, observed depression), each rated from 0 (absent) to
3 (severe). Ratings > 6 on the total score indicate clinically significant
depression (Rybakowski et al., 2012). The Italian translation of the
CDSS is available on the official website (http://www.ucalgary.ca/
cdss/).
2.3.2. Independent variables
Avolition and expressive deficit were assessed using the Brief
Negative Symptom Scale (BNSS) which includes 13 items, rated from 0
(normal) to 6 (most impaired), and five negative symptoms domains:
anhedonia, asociality, avolition, blunted affect and alogia. In line with
previous research, domains evaluated by the scale loaded on two fac-
tors: “avolition”, consisting of anhedonia, asociality and avolition, and
“poor emotional expression”, including blunted affect and alogia
(Kirkpatrick et al., 2011; Mucci et al., 2015; Strauss and Gold, 2016).
Resilience was assessed using the Resilience Scale for Adults (RSA)
(Friborg et al., 2005). This is a self-administered instrument including
33 items that examine intra- and inter-personal protective factors
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thought to facilitate adaptation when facing psychosocial adversity.
Items are organized into six factors: perception of self, planned future,
structured style, social competence, family cohesion, and social re-
sources. In this study we used ‘personal strength’ as a factor containing
perception of self and planned future (Friborg et al., 2005). ‘Personal
strength’ measures the level of self-esteem, self-efficacy, self-liking,
hope, determination and a realistic orientation to life. ‘Social compe-
tence’ measures extraversion, social adeptness, cheerful mood, an
ability to initiate activities, good communication skills and flexibility in
social matters.’Family cohesion’ measures shared values, ability to
enjoy family, cohesion, shared optimistic view of future, loyalty, mu-
tual appreciation. ‘Structured style’ measures goal oriented planning
ability. ‘Social resources’ measures social support, presence of im-
portant persons outside family and feeling of cohesion (Capanna et al.,
2015; Friborg et al., 2005).
The experience of stigma and internalized self-rejection was eval-
uated using the Internalized Stigma of Mental Illness (ISMI) (Ritsher
et al., 2003; for Italian version see Brohan et al. (2010)). This includes
29 items and 5 subscales for self-assessment of subjective experience of
stigma. Each item is rated on a 4-level Likert scale, where higher scores
indicate greater levels of internalized stigma (Ritsher and Phelan,
2004).
2.4. Statistical analysis
A SEM model was used to analyze the relationship of depression
with gender, avolition, poor emotional expressivity, stigma and resi-
lience based on an a priori theoretical model. Gender, avolition and
poor emotional expressivity were used as exogenous variables, and
stigma and resilience as mediators. A latent variable for resilience was
used, identified by the five items of structured style, social competence,
family cohesion, social resources and personal strength. The CDSS
variable was transformed in its square root in order to normalize its
distribution. All possible paths connecting these variables were traced,
and those non-significant (p> 0.05) were removed from the model.
Standardized path coefficients were obtained, in order to compare
paths pointing to the same dependent variable. Correlations between
pairs of items of resilience were added when useful to improve the
model fit. The goodness of fit of the final model was assessed using
RMSEA, CFI and TLI statistic, with RMSEA<0.080 (Browne and
Cudeck, 1993), CFI> 0.900 and TLI> 0.900 (Hu and Bentler, 1999)
denoting good or acceptable fit.
Stata 13.1 was used for descriptive analyses and Mplus 7.4 for the
SEM analysis.
3. Results
Out of 1691 screened patients, 1180 were eligible for the NIRP
study; of these, 202 refused to participate, 57 failed to complete the
assessments and 921 were included. In accordance with the study
protocol, clinical and demographic data were not required to patients
who refused to participate and were not retained for those who dropped
out the procedures.
Table 1 shows that the study population consists mainly of males
(69.6%), had a mean age of 40.2 years and received the first treatment
of psychosis at 24.0 years. Almost one-third (29.2%) was working at the
time of the interview and more than two thirds (68.5%) received aty-
pical antipsychotic treatment.
Twenty-eight percent of the clinical sample reported clinical de-
pression according to CDSS cut-off point of > 6.
Correlations among depression and the variables selected for the
SEM model were over 0.20, except for three items related to the latent
construct of resilience (Table 2).
In the SEM model shown in Fig. 1 higher avolition, lower resilience,
higher stigma and female gender were associated with higher levels of
depression. Gender, avolition and resilience were directly related to
depression, while stigma connected to depression by the mediation of
resilience. Avolition was also indirectly related with depression through
stigma and resilience. Poor emotional expressivity was removed from
the model because it was unrelated to all the other variables. As shown
in Table 3, resilience had the strongest direct effect on CDSS (b =
−0.301, p<0.001), but overall the covariate most associated with
depression through direct and indirect pathways was avolition (total b
= 0.336, p<0.001, b = 0.246 indirect effect, b = 0.090 direct effect).
The model explained 20.1% of the variance of CDSS and had a good fit
to the data (RMSEA = 0.046, CFI = 0.978, TLI = 0.965).
4. Discussion
With the present study we sought to explore the association between
personal resources and depression in patients with schizophrenia. To
the best of our knowledge, this is the first single study addressing this
issue using a SEM model on such a large cohort. Moreover, this is the
first study that specifically investigates the relationships between de-
pression and negative symptoms in schizophrenia using newly devel-
oped negative symptom scales such as the BNSS.
In line with previous findings, 28% of clinical sample reported
clinical depression according to CDSS cut-off point of > 6 (Dan et al.,
2011; Rybakowski et al., 2012). From a psychopathological perspec-
tive, we found that both personal resources and negative symptoms
concurred to depression. Interestingly, we found that only BNSS plea-
sure and motivation items (i.e. BNSS avolition) showed a significant
association with depression, while the emotional expressivity factor did
not. In so far as anhedonia represents a core symptom of major de-
pression (Fletcher et al., 2015), this is not surprising. On the other
hand, the lack of association of depression severity with emotional
expressivity further supports the separation of the two BNSS factors
(Strauss and Gold, 2016).
Inconsistencies in the correlations between depression and negative
symptoms reported in the literature may be due to differences in the
instruments used, as well as in the patients selection criteria. For ex-
ample, Rabany et al. (2011) reported a low negative correlation be-
tween the Scale for Assessment of Negative Symptoms (SANS) and
CDSS, but their sample was made up of schizophrenia patients with
predominantly negative symptoms. In our model avolition has the
highest total effect on depression while resilience shows the highest
Table 1
Characteristics of the study population.
Variable N Mean (SD) or %
Education (years) 919 11.61 (3.43)
Age 921 40.17 (10.71)
Age at onset 918 24.02 (7.20)
Antipsychotic treatment 921
Typical 14.2%
Atypical 68.5%
Both 14.1%
None 3.2%
Gender (% males) 921 69.6%
Work (% currently working) 893 29.2%
BNSS avolition 920 20.66(9.64)
BNSS poor emotional expressivity 920 12.84(8.03)
RSA ‘structured style’ 912 13.08 (3.43)
RSA ‘social resources’ 912 25.17 (5.94)
RSA ‘social competence’ 910 18.89 (5.32)
RSA ‘family cohesion’ 912 20.34 (5.74)
RSA ‘personal strength’ 911 28.96 (8.95)
ISMI 910 2.20(0.44)
CDSS 920 3.99 (4.02)
CDSS ≥6 920 28.5%
Abbreviations. BNSS: Brief Negative Symptom Scale; RSA: Resilience Scale for Adults;
ISMI: Internalized Stigma of Mental Illness; CDSS: Calgary Depression Scale for
Schizophrenia.
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direct effect. Treatments aimed to improve avolition could ha a positive
impact on depression directly but also improving resilience.
In our model, low resilience was associated with higher levels of
depression. Furthermore, higher resilience coupled with lower avolition
indicate protection towards depression, balancing the subjective ex-
periences of psychological deficits reported by Liddle and Barnes
(1988), Liddle et al. (1993). It could be argued that what we called
‘personal resources’ could simply be the other face of the self-perceived
psychological deficit. Nevertheless, the issue of ‘positive’ resources
opens new opportunities to investigate outcome variability in schizo-
phrenia.
High internalized stigma was associated with higher depression,
consistent with other studies reporting that interventions aimed at re-
ducing stigma might contribute to improve depression (Drapalski et al.,
2013; Gerlinger et al., 2013; Lysaker et al., 2013; Park et al., 2013). Our
study refines this perspective by highlighting the role of resilience as a
mediator between stigma and depression.
We found that female gender was associated with higher depression
severity. This finding is not consistent with some prior reports: more
severe depressive symptoms were previously reported in male patients
(Rocca et al., 2005), and a positive correlation between depression
severity and positive symptoms was also found in male patients with
schizophrenia (Müller, 2007). This discrepancy may be due to differ-
ences in the samples. However, the NIRP study, for its size and design,
should have helped in reducing selection bias better than prior in-
vestigations.
4.1. Clinical implications
Clinical strategies targeting resilience could be studied in depth and
eventually tested within the recovery approach (Hofer et al., 2016;
Yoshida et al., 2016). Because of the complex interaction between
subjective and objective elements of recovery (Jørgensen et al., 2015),
strategies aimed at improving resilience could ultimately improve re-
covery (Borras et al., 2009). ‘Personal strength’ measures levels of self-
efficacy, self-liking, hope, determination and a realistic orientation to
life (Capanna et al., 2015; Friborg et al., 2003, 2005; Hjemdal et al.,
2006). In our study personal strength was the item more strongly cor-
related with the latent construct of resilience, suggesting a high re-
levance of the individual and personal aspect of resilience in buffering
depression. Including this item in its definition expands resilience's role
as a protective factor toward psychiatric symptoms (Hjemdal et al.,
2006). This psychological approach could be further reshaped into the
‘subjective recovery perspective’, as suggested by Hofer et al. (2016).
The role of ‘personal resources’ suggests that some positive features of
adjustment to psychosis may reduce the burden of depression, which, in
turn, could have a positive impact on the disorder itself.
The role of positive psychological variables such as resilience and
even happiness has not been systematically evaluated among people
with schizophrenia or other serious mental illnesses (Palmer et al.,
2014), but the “wellness within illness” issue (Saks, 2013) deserves
further exploration.
4.2. Strengths and limitations
Among the limitations of the study, our model was based on cross-
sectional data, which prevent to infer causal relationships among
variables. Moreover, the explained variance of depression was quite low
(20.1%), although in line with other studies exploring psychological
models of depression in schizophrenia (Xu et al., 2013). We are aware
that we limited the exploration of personal and psychological resources
to self-stigma and resilience, while other constructs, such as self-esteem
and insight, could have a role to predict clinical outcomes and de-
pression (Lysaker et al., 2007, 2013; Mashiach-Eizenberg et al., 2013;
Xu et al., 2013). However the model we report could be further en-
riched in the perspective to include other variables in the causal chainTa
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leading to depression in schizophrenia.
The ‘psychological’ nature of depression in schizophrenia seems to
offer a wide perspective to psychological oriented approaches.
Improving ‘personal resources’ could contribute to produce a more
positive outcome, at least in part of the cases (Vass et al., 2015; Palmer
et al., 2014; Yanos et al., 2008).
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